Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Middlefield Healthcare & Life Sciences Dividend Fund is a Canadian closed-end investment fund designed to provide unitholders with stable monthly cash distributions and capital appreciation. The fund invests in a diversified portfolio of equity securities from global issuers operating in the healthcare and life sciences sectors, including pharmaceuticals, biotechnology, and medical technology. Managed by Middlefield Limited, the fund employs an active management strategy to identify high-quality companies with sustainable dividends and strong growth potential. It utilizes covered call options on a portion of the portfolio to enhance income and mitigate volatility. The fund is publicly traded on the Toronto Stock Exchange and offers investors exposure to the defensive and growth characteristics of the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Middlefield Healthcare & Life Sciences Dividend Fund.